Mumps measles rubella vaccine
|Trade names||M-M-R II, Priorix, Tresivac, Trimovax, others|
|AHFS/Drugs.com||Multum Consumer Information|
|(what is this?)|
The first dose is given to children around 9 to 15 months of age, with a second dose at 15 months to 6 years of age, with at least 4 weeks between the doses. After two doses 97% of people are protected against measles, 88% against mumps, and at least 97% against rubella.
References[change | change source]
- Grignolio, Andrea (2018). Vaccines: Are they Worth a Shot?. Springer. p. 2. ISBN 9783319681061.
- "MMR Vaccination What You Should Know Measles, Mumps, Rubella". CDC. 2 February 2018. Retrieved 10 September 2018.
- "Measles vaccines: WHO position paper – April 2017". Releve Epidemiologique Hebdomadaire. 92 (17): 205–27. 28 April 2017. PMID 28459148.
- Kinney, Rebecca (2 May 2017). "Core Concepts - Immunizations in Adults - Basic HIV Primary Care - National HIV CurriculumImmunizations in Adults". www.hiv.uw.edu.
- Watson, JC; Hadler, SC; Dykewicz, CA; Reef, S; Phillips, L (22 May 1998). "Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP)". MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports. 47 (RR-8): 1–57. PMID 9639369.